김동욱 교수,가톨릭혈액병원장
#조혈모세포이식#EBS명의#헬스조선명의
|
학력
1979~1985 가톨릭대학교 의학 학사
1987~1992 가톨릭대학교 내과학 석사
1992~1996 가톨릭대학교 내과학 박사
1987~1992 가톨릭대학교 내과학 석사
1992~1996 가톨릭대학교 내과학 박사
경력
2018~현재 가톨릭혈액병원장
2017~2018 서울성모병원 BMT 센터장
2015~현재 가톨릭의과대학교 백혈병연구소장
2015~2017 서울성모병원 혈액내과분과장
2011~2017 서울성모병원 암병원 연구부장
2012~2016 가톨릭의과대학교 혈액내과 학과장
2011~2015 가톨릭의과대학교 암연구소장
2003~2012 가톨릭의과대학교 분자유전학연구소장
1994~1994 삼성서울병원 내과 전문의
1992~1994 여의도성모병원 내과 임상강사
1986~1989 가톨릭중앙의료원 내과 레지던트
1985~1986 가톨릭중앙의료원 인턴
2017~2018 서울성모병원 BMT 센터장
2015~현재 가톨릭의과대학교 백혈병연구소장
2015~2017 서울성모병원 혈액내과분과장
2011~2017 서울성모병원 암병원 연구부장
2012~2016 가톨릭의과대학교 혈액내과 학과장
2011~2015 가톨릭의과대학교 암연구소장
2003~2012 가톨릭의과대학교 분자유전학연구소장
1994~1994 삼성서울병원 내과 전문의
1992~1994 여의도성모병원 내과 임상강사
1986~1989 가톨릭중앙의료원 내과 레지던트
1985~1986 가톨릭중앙의료원 인턴
논문
2020 Nov
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION 공동저자
Comparison of Myeloablative (CyTBI, BuCy) versus Reduced-Intensity (FluBu2TBI400) Peripheral Blood Stem Cell Transplantation in Acute Myeloid Leukemia Patients with Pretransplant Low WT1 Expression
2020 Oct
EUROPEAN JOURNAL OF HAEMATOLOGY 공동저자
Non-myeloablative matched sibling stem cell transplantation with the optional reinforced stem cell infusion for patients with hemoglobinopathies
2020 Oct
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS 교신저자
Development of a dried blood spot sampling method towards therapeutic monitoring of radotinib in the treatment of chronic myeloid leukaemia
2020 Oct
HLA 공동저자
Specific donor HLA allotypes as predictors of cytomegalovirus disease risk in acute myeloid leukemia
2020 Sep
NATURE COMMUNICATIONS 공동저자
The lysophospholipase D enzyme Gdpd3 is required to maintain chronic myelogenous leukaemia stem cells
2020 Aug
LEUKEMIA 공동저자
Dasatinib vs. imatinib in patients with chronic myeloid leukemia in chronic phase (CML-CP) who have not achieved an optimal response to 3 months of imatinib therapy: the DASCERN randomized study
2020 Jul
FRONTIERS IN ONCOLOGY 교신저자
Nilotinib-Induced Immune-Mediated Liver Injury: Corticosteroid as a Possible Therapeutic Option
2020 Jul
SENSORS AND ACTUATORS B-CHEMICAL 공동저자
Fluorometric detection of single-nucleotide mutations using tandem gene amplification
2020 Jul
BRITISH JOURNAL OF HAEMATOLOGY 교신저자
Successful prevention and screening strategies for COVID-19: focus on patients with haematologic diseases
2020 May
CLINICAL EPIGENETICS 공동저자
Novel HDAC inhibitor MAKV-8 and imatinib synergistically kill chronic myeloid leukemia cells via inhibition of BCR-ABL/MYC-signaling: effect on imatinib resistance and stem cells
2020 May
ANNALS OF HEMATOLOGY 공동저자
Safety and efficacy of arsenic trioxide and all-trans retinoic acid therapy in acute promyelocytic leukemia patients with a high risk for early death
2020 Apr
LEUKEMIA 공동저자
European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia
2020 Apr
BRITISH JOURNAL OF HAEMATOLOGY 교신저자
Long-term data from a phase 3 study of radotinib versus imatinib in patients with newly diagnosed, chronic myeloid leukaemia in the chronic phase (RERISE)
2020 Mar
ANNALS OF HEMATOLOGY 공동저자
Poor prognosis in patients with diffuse large B cell lymphomas with bone marrow involvement possessing chromosomal abnormalities, despite aggressive treatment
2020 Mar
INTERNATIONAL JOURNAL OF HEMATOLOGY 교신저자
Comprehensive analyses of safety and efficacy toward individualizing imatinib dosage in patients with chronic myeloid leukemia
2020 Feb
CELL DEATH & DISEASE 공동저자
Tetrahydrobenzimidazole TMQ0153 triggers apoptosis, autophagy and necroptosis crosstalk in chronic myeloid leukemia
2019 Dec
NEW ENGLAND JOURNAL OF MEDICINE 교신저자
Asciminib in Chronic Myeloid Leukemia after ABL Kinase Inhibitor Failure
2019 Dec
AUTOPHAGY 교신저자
GCA links TRAF6-ULK1-dependent autophagy activation in resistant chronic myeloid leukemia
2019 Dec
New England Journal of Medicine(NEJM / IF=70.670) 교신저자
Asciminib in Chronic Myeloid Leukemia after ABL Kinase Inhibitor Failure
2019 Dec
CANCER MEDICINE 공동저자
Feasible outcome of blinatumomab followed by allogeneic hematopoietic cell transplantation for adults with Philadelphia chromosome?negative acute lymphoblastic leukemia in first salvage
2019 Nov
INTERNATIONAL JOURNAL OF HEMATOLOGY 공동저자
A case of central nervous system graft-versus-host disease following allogeneic stem cell transplantation
2019 Oct
CANCER CELL 공동저자
Combining the Allosteric Inhibitor Asciminib with Ponatinib Suppresses Emergence of and Restores Efficacy against Highly Resistant BCR-ABL1 Mutants
2019 Oct
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION 공동저자
Alteration of the Intestinal Microbiota by Broad-Spectrum Antibiotic Use Correlates with the Occurrence of Intestinal Graft-versus-Host Disease
2019 Oct
DIGESTIVE DISEASES AND SCIENCES 공동저자
Early Hepatitis B Surface Antigen Seroclearance Following Antiviral Treatment in Patients with Reactivation of Resolved Hepatitis B
2019 Oct
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION 공동저자
WT1 measurable residual disease assay in patients with acute myeloid leukemia who underwent allogeneic hematopoietic stem cell transplantation: Optimal Time Points, Thersholds, and Candidates
2019 Sep
HAEMATOLOGICA 공동저자
De novo UBE2A mutations are recurrently acquired during chronic myeloid leukemia progression and interfere with myeloid differentiation pathways
2019 Aug
LEUKEMIA 공동저자
Laying the foundation for genomically-based risk assessment in chronic myeloid leukemia
2019 Jul
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA 교신저자
Optimal Time Points for BCR-ABL1 Tyrosine Kinase Domain Mutation Analysis on the Basis of European LeukemiaNet Recommendations in Chronic Myeloid Leukemia
2019 Jun
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY 공동저자
Patient-reported outcomes in the phase 3 BFORE trial of bosutinib versus imatinib for newly diagnosed chronic phase chronic myeloid leukemia
2019 Mar
CANCER 공동저자
Minimal residual disease-based long-term efficacy of reduced-intensity conditioning versus myeloablative conditioning for adult Philadelphia-positive acute lymphoblastic leukemia
2019 Feb
JOURNAL FOR IMMUNOTHERAPY OF CANCER 공동저자
Different role of circulating myeloid-derived suppressor cells in patients with multiple myeloma undergoing autologous stem cell transplantation
2019 Jan
LEUKEMIA RESEARCH 교신저자
Compound mutations involving T315I and P-loop mutations are the major components of multiple mutations detected in tyrosine kinase inhibitor resistant chronic myeloid leukemia
2018 Dec
CANCER LETTERS 공동저자
Hydroxycoumarin OT-55 kills CML cells alone or in synergy with imatinib or Synribo: Involvement of ER stress and DAMP release
2018 Nov
ANNALS OF HEMATOLOGY 공동저자
Low frequency of CD3(+)CD4(+)CD161(+) T cells correlates with the occurrence of infections in refractory/relapsed multiple myeloma patients receiving lenalidomide plus low-dose dexamethasone treatment
2018 Nov
AMERICAN JOURNAL OF HEMATOLOGY 공동저자
Optimal conditioning regimen for haplo-identical stem cell transplantation in adult patients with acquired severe aplastic anemia: Prospective de-escalation study of TBI and ATG dose
2018 Oct
CANCER MEDICINE 교신저자
BCR-ABL1 transcript levels at 4 weeks have prognostic significance for time-specific responses and for predicting survival in chronic-phase chronic myeloid leukemia patients treated with various tyrosine kinase inhibitors
2018 Oct
MEDICINE 공동저자
Cutaneous comorbidities in patients with multiple myeloma: A 10-year retrospective cohort study from a Korean population
2018 Oct
BONE MARROW TRANSPLANTATION 공동저자
Successful outcomes of second hematopoietic stem cell transplantation with total nodal irradiation and ATG conditioning for graft failure in adult patients with severe aplastic anemia
2018 Oct
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA 교신저자
Comparison of Frequency and Sensitivity of BCR-ABL1 Kinase Domain Mutations in Asian and White Patients With Imatinib-resistant Chronic-Phase Chronic Myeloid Leukemia
2018 Sep
BLOOD CANCER JOURNAL 공동저자
Long-term efficacy and safety of dasatinib in patients with chronic myeloid leukemia in accelerated phase who are resistant to or intolerant of imatinib
2018 Aug
ANNALS OF HEMATOLOGY 교신저자
Outcomes of switching to dasatinib after imatinib-related low-grade adverse events in patients with chronic myeloid leukemia in chronic phase: the DASPERSE study
2018 Aug
EUROPEAN JOURNAL OF HAEMATOLOGY 공동저자
Comparison of transplant-specific prognostic scoring systems in haploidentical transplantation for myelodysplastic syndrome
2018 Aug
BLOOD 공동저자
Integrative genomic analysis reveals cancer-associated mutations at diagnosis of CML in patients with high-risk disease
2018 Aug
HAEMATOLOGICA 공동저자
Safety and efficacy of second-line bosutinib for chronic phase chronic myeloid leukemia over a five-year period: final results of a phase I/II study
2018 Aug
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION 공동저자
Impact of an Additional Chromosome on the Clinical Outcomes of Hematopoietic Stem Cell Transplantation in Philadelphia Chromosome-Positive Acute Myeloid Leukemia in Adults
2018 Jul
BLOOD 공동저자
Ponatinib efficacy and safety in Philadelphia chromosome-positive leukemia: final 5-year results of the phase 2 PACE trial
2018 Jun
INFECTION AND CHEMOTHERAPY 공동저자
Cytomegalovirus Colitis during Dasatinib Treatment for Patients with Hematologic Malignancy: Case Series and Literature Review
2018 Jun
BLOOD RESEARCH(구 대한혈액학회지/2013년 이후 게재) 공동저자
Effectiveness of darbepoetin alfa in multiple myeloma patients receiving chemotherapy including novel agents
2018 May
CANCER MEDICINE 교신저자
Determination of a radotinib dosage regimen based on dose-response relationships for the treatment of newly diagnosed patients with chronic myeloid leukemia
2018 Apr
ANNALS OF INTERNAL MEDICINE 공동저자
Treatment-Free Remission After Second-Line Nilotinib Treatment in Patients With Chronic Myeloid Leukemia in Chronic Phase: Results From a Single-Group, Phase 2, Open-Label Study
2018 Apr
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA 공동저자
Prognostic Prediction Model for Second Allogeneic Stem-Cell Transplantation in Patients With Relapsed Acute Myeloid Leukemia: Single-Center Report
2018 Mar
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY 공동저자
Prevalence and clinicopathologic characteristics of multiple myeloma with cutaneous involvement: A case series from Korea
2018 Jan
ONCOTARGET 공동저자
Comparison of the modified low-dose cytarabine and etoposide with decitabine therapy for elderly acute myeloid leukemia patients unfit for intensive chemotherapy
2018 Jan
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION 공동저자
Matrix Metalloproteinase-9 in Monocytic Myeloid-Derived Suppressor Cells Correlate with Early Infections and Clinical Outcomes in Allogeneic Hematopoietic Stem Cell Transplantation
2018 Jan
LEUKEMIA & LYMPHOMA 교신저자
Baseline BCR-ABL1 transcript type of e13a2 and large spleen size are predictors of poor long-term outcomes in chronic phase chronic myeloid leukemia patients who failed to achieve an early molecular response after 3 months of imatinib therapy
2018 Jan
BIOMED RESEARCH INTERNATIONAL 공동저자
Circulating CD3+CD4+CD161+ Cells Are Associated with Early Complications after Autologous Stem Cell Transplantation in Multiple Myeloma
2018 Jan
JOURNAL OF CLINICAL ONCOLOGY 공동저자
Bosutinib Versus Imatinib for Newly Diagnosed Chronic Myeloid Leukemia: Results From the Randomized BFORE Trial
2017 Dec
Clinical Cancer Research 교신저자
Phase III clinical trial (RERISE study) results of Efficacy and safety of radotinib compared with imatinib in newly diagnosed chronic phase chronic myeloid leukemia.
2017 Aug
Cancer 공동저자
Overall survival with ponatinib versus allogeneic stem cell transplantation in Philadelphia chromosome-positive leukemias with the T315I mutation.
2017 Aug
대한면역학회 공동저자
Distinct Clinical Outcomes between Paramedullary and Extramedullary Lesions in Newly Diagnosed Multiple Myeloma
2017 Jul
Leukemia 교신저자
Cobll1 is linked to drug resistance and blastic transformation in chronic myeloid leukemia.
2017 Jun
Oncotarget 공동저자
Long-term clinical outcomes of hematopoietic cell transplantation for intermediate-to-poor-risk acute myeloid leukemia during first remission according to available donor types.
2017 May
Clinica Chimica Acta 공동저자
Practical informativeness of short tandem repeat loci for chimerism analysis in hematopoietic stem cell transplantation.
2017 Apr
Biology of Blood and Marrow Transplantation 공동저자
Clinical Outcome of Autologous Hematopoietic Cell Transplantation in Adult Patients with Acute Myeloid Leukemia: Who May Benefit from Autologous Hematopoietic Cell Transplantation?
2017 Mar
PLoS One 공동저자
The demanding attention of tuberculosis in allogeneic hematopoietic stem cell transplantation recipients: High incidence compared with general population.
2017 Feb
Transplant Infectious Disease 공동저자
Clinical significance of pre-transplant circulating CD3+ CD4+ CD161+ cell frequency on the occurrence of neutropenic infections after allogeneic stem cell transplantation.
2017 Feb
Oncotarget 공동저자
Better transplant outcome with pre-transplant marrow response after hypomethylating treatment in higher-risk MDS with excess blasts
2017 Jan
Journal of Hematology & Oncology 공동저자
High WT1 expression is an early predictor for relapse in patients with acute promyelocytic leukemia in first remission with negative PML-RARa after anthracycline-based chemotherapy: a single-center cohort study.
2017 Jan
Clinical Lymphoma Myeloma and Leukemia 공동저자
Characteristics and Survival Outcome Analysis of Extramedullary Involvement in Adult Patients With t(8;21) Acute Myeloid Leukemia.
2017 Jan
Korean journal of internal medicine 교신저자
BCR-ABL1 transcripts (MR4.5) at post-transplant 3 months as an early predictor for long-term outcomes in chronic myeloid leukemia
2017 Jan
대한내과학회 교신저자
BCR-ABL1 transcripts (MR4.5) at post-transplant 3 months as an early predictor for long-term outcomes in chronic myeloid leukemia
2017 Jan
Acta Derm Venereol 공동저자
Eruptive Melanocytic Naevi Caused by Radotinib Therapy in Patients with Chronic Myeloid Leukaemia: 10 cases and a literature Review.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION 공동저자
Comparison of Myeloablative (CyTBI, BuCy) versus Reduced-Intensity (FluBu2TBI400) Peripheral Blood Stem Cell Transplantation in Acute Myeloid Leukemia Patients with Pretransplant Low WT1 Expression
2020 Oct
EUROPEAN JOURNAL OF HAEMATOLOGY 공동저자
Non-myeloablative matched sibling stem cell transplantation with the optional reinforced stem cell infusion for patients with hemoglobinopathies
2020 Oct
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS 교신저자
Development of a dried blood spot sampling method towards therapeutic monitoring of radotinib in the treatment of chronic myeloid leukaemia
2020 Oct
HLA 공동저자
Specific donor HLA allotypes as predictors of cytomegalovirus disease risk in acute myeloid leukemia
2020 Sep
NATURE COMMUNICATIONS 공동저자
The lysophospholipase D enzyme Gdpd3 is required to maintain chronic myelogenous leukaemia stem cells
2020 Aug
LEUKEMIA 공동저자
Dasatinib vs. imatinib in patients with chronic myeloid leukemia in chronic phase (CML-CP) who have not achieved an optimal response to 3 months of imatinib therapy: the DASCERN randomized study
2020 Jul
FRONTIERS IN ONCOLOGY 교신저자
Nilotinib-Induced Immune-Mediated Liver Injury: Corticosteroid as a Possible Therapeutic Option
2020 Jul
SENSORS AND ACTUATORS B-CHEMICAL 공동저자
Fluorometric detection of single-nucleotide mutations using tandem gene amplification
2020 Jul
BRITISH JOURNAL OF HAEMATOLOGY 교신저자
Successful prevention and screening strategies for COVID-19: focus on patients with haematologic diseases
2020 May
CLINICAL EPIGENETICS 공동저자
Novel HDAC inhibitor MAKV-8 and imatinib synergistically kill chronic myeloid leukemia cells via inhibition of BCR-ABL/MYC-signaling: effect on imatinib resistance and stem cells
2020 May
ANNALS OF HEMATOLOGY 공동저자
Safety and efficacy of arsenic trioxide and all-trans retinoic acid therapy in acute promyelocytic leukemia patients with a high risk for early death
2020 Apr
LEUKEMIA 공동저자
European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia
2020 Apr
BRITISH JOURNAL OF HAEMATOLOGY 교신저자
Long-term data from a phase 3 study of radotinib versus imatinib in patients with newly diagnosed, chronic myeloid leukaemia in the chronic phase (RERISE)
2020 Mar
ANNALS OF HEMATOLOGY 공동저자
Poor prognosis in patients with diffuse large B cell lymphomas with bone marrow involvement possessing chromosomal abnormalities, despite aggressive treatment
2020 Mar
INTERNATIONAL JOURNAL OF HEMATOLOGY 교신저자
Comprehensive analyses of safety and efficacy toward individualizing imatinib dosage in patients with chronic myeloid leukemia
2020 Feb
CELL DEATH & DISEASE 공동저자
Tetrahydrobenzimidazole TMQ0153 triggers apoptosis, autophagy and necroptosis crosstalk in chronic myeloid leukemia
2019 Dec
NEW ENGLAND JOURNAL OF MEDICINE 교신저자
Asciminib in Chronic Myeloid Leukemia after ABL Kinase Inhibitor Failure
2019 Dec
AUTOPHAGY 교신저자
GCA links TRAF6-ULK1-dependent autophagy activation in resistant chronic myeloid leukemia
2019 Dec
New England Journal of Medicine(NEJM / IF=70.670) 교신저자
Asciminib in Chronic Myeloid Leukemia after ABL Kinase Inhibitor Failure
2019 Dec
CANCER MEDICINE 공동저자
Feasible outcome of blinatumomab followed by allogeneic hematopoietic cell transplantation for adults with Philadelphia chromosome?negative acute lymphoblastic leukemia in first salvage
2019 Nov
INTERNATIONAL JOURNAL OF HEMATOLOGY 공동저자
A case of central nervous system graft-versus-host disease following allogeneic stem cell transplantation
2019 Oct
CANCER CELL 공동저자
Combining the Allosteric Inhibitor Asciminib with Ponatinib Suppresses Emergence of and Restores Efficacy against Highly Resistant BCR-ABL1 Mutants
2019 Oct
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION 공동저자
Alteration of the Intestinal Microbiota by Broad-Spectrum Antibiotic Use Correlates with the Occurrence of Intestinal Graft-versus-Host Disease
2019 Oct
DIGESTIVE DISEASES AND SCIENCES 공동저자
Early Hepatitis B Surface Antigen Seroclearance Following Antiviral Treatment in Patients with Reactivation of Resolved Hepatitis B
2019 Oct
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION 공동저자
WT1 measurable residual disease assay in patients with acute myeloid leukemia who underwent allogeneic hematopoietic stem cell transplantation: Optimal Time Points, Thersholds, and Candidates
2019 Sep
HAEMATOLOGICA 공동저자
De novo UBE2A mutations are recurrently acquired during chronic myeloid leukemia progression and interfere with myeloid differentiation pathways
2019 Aug
LEUKEMIA 공동저자
Laying the foundation for genomically-based risk assessment in chronic myeloid leukemia
2019 Jul
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA 교신저자
Optimal Time Points for BCR-ABL1 Tyrosine Kinase Domain Mutation Analysis on the Basis of European LeukemiaNet Recommendations in Chronic Myeloid Leukemia
2019 Jun
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY 공동저자
Patient-reported outcomes in the phase 3 BFORE trial of bosutinib versus imatinib for newly diagnosed chronic phase chronic myeloid leukemia
2019 Mar
CANCER 공동저자
Minimal residual disease-based long-term efficacy of reduced-intensity conditioning versus myeloablative conditioning for adult Philadelphia-positive acute lymphoblastic leukemia
2019 Feb
JOURNAL FOR IMMUNOTHERAPY OF CANCER 공동저자
Different role of circulating myeloid-derived suppressor cells in patients with multiple myeloma undergoing autologous stem cell transplantation
2019 Jan
LEUKEMIA RESEARCH 교신저자
Compound mutations involving T315I and P-loop mutations are the major components of multiple mutations detected in tyrosine kinase inhibitor resistant chronic myeloid leukemia
2018 Dec
CANCER LETTERS 공동저자
Hydroxycoumarin OT-55 kills CML cells alone or in synergy with imatinib or Synribo: Involvement of ER stress and DAMP release
2018 Nov
ANNALS OF HEMATOLOGY 공동저자
Low frequency of CD3(+)CD4(+)CD161(+) T cells correlates with the occurrence of infections in refractory/relapsed multiple myeloma patients receiving lenalidomide plus low-dose dexamethasone treatment
2018 Nov
AMERICAN JOURNAL OF HEMATOLOGY 공동저자
Optimal conditioning regimen for haplo-identical stem cell transplantation in adult patients with acquired severe aplastic anemia: Prospective de-escalation study of TBI and ATG dose
2018 Oct
CANCER MEDICINE 교신저자
BCR-ABL1 transcript levels at 4 weeks have prognostic significance for time-specific responses and for predicting survival in chronic-phase chronic myeloid leukemia patients treated with various tyrosine kinase inhibitors
2018 Oct
MEDICINE 공동저자
Cutaneous comorbidities in patients with multiple myeloma: A 10-year retrospective cohort study from a Korean population
2018 Oct
BONE MARROW TRANSPLANTATION 공동저자
Successful outcomes of second hematopoietic stem cell transplantation with total nodal irradiation and ATG conditioning for graft failure in adult patients with severe aplastic anemia
2018 Oct
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA 교신저자
Comparison of Frequency and Sensitivity of BCR-ABL1 Kinase Domain Mutations in Asian and White Patients With Imatinib-resistant Chronic-Phase Chronic Myeloid Leukemia
2018 Sep
BLOOD CANCER JOURNAL 공동저자
Long-term efficacy and safety of dasatinib in patients with chronic myeloid leukemia in accelerated phase who are resistant to or intolerant of imatinib
2018 Aug
ANNALS OF HEMATOLOGY 교신저자
Outcomes of switching to dasatinib after imatinib-related low-grade adverse events in patients with chronic myeloid leukemia in chronic phase: the DASPERSE study
2018 Aug
EUROPEAN JOURNAL OF HAEMATOLOGY 공동저자
Comparison of transplant-specific prognostic scoring systems in haploidentical transplantation for myelodysplastic syndrome
2018 Aug
BLOOD 공동저자
Integrative genomic analysis reveals cancer-associated mutations at diagnosis of CML in patients with high-risk disease
2018 Aug
HAEMATOLOGICA 공동저자
Safety and efficacy of second-line bosutinib for chronic phase chronic myeloid leukemia over a five-year period: final results of a phase I/II study
2018 Aug
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION 공동저자
Impact of an Additional Chromosome on the Clinical Outcomes of Hematopoietic Stem Cell Transplantation in Philadelphia Chromosome-Positive Acute Myeloid Leukemia in Adults
2018 Jul
BLOOD 공동저자
Ponatinib efficacy and safety in Philadelphia chromosome-positive leukemia: final 5-year results of the phase 2 PACE trial
2018 Jun
INFECTION AND CHEMOTHERAPY 공동저자
Cytomegalovirus Colitis during Dasatinib Treatment for Patients with Hematologic Malignancy: Case Series and Literature Review
2018 Jun
BLOOD RESEARCH(구 대한혈액학회지/2013년 이후 게재) 공동저자
Effectiveness of darbepoetin alfa in multiple myeloma patients receiving chemotherapy including novel agents
2018 May
CANCER MEDICINE 교신저자
Determination of a radotinib dosage regimen based on dose-response relationships for the treatment of newly diagnosed patients with chronic myeloid leukemia
2018 Apr
ANNALS OF INTERNAL MEDICINE 공동저자
Treatment-Free Remission After Second-Line Nilotinib Treatment in Patients With Chronic Myeloid Leukemia in Chronic Phase: Results From a Single-Group, Phase 2, Open-Label Study
2018 Apr
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA 공동저자
Prognostic Prediction Model for Second Allogeneic Stem-Cell Transplantation in Patients With Relapsed Acute Myeloid Leukemia: Single-Center Report
2018 Mar
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY 공동저자
Prevalence and clinicopathologic characteristics of multiple myeloma with cutaneous involvement: A case series from Korea
2018 Jan
ONCOTARGET 공동저자
Comparison of the modified low-dose cytarabine and etoposide with decitabine therapy for elderly acute myeloid leukemia patients unfit for intensive chemotherapy
2018 Jan
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION 공동저자
Matrix Metalloproteinase-9 in Monocytic Myeloid-Derived Suppressor Cells Correlate with Early Infections and Clinical Outcomes in Allogeneic Hematopoietic Stem Cell Transplantation
2018 Jan
LEUKEMIA & LYMPHOMA 교신저자
Baseline BCR-ABL1 transcript type of e13a2 and large spleen size are predictors of poor long-term outcomes in chronic phase chronic myeloid leukemia patients who failed to achieve an early molecular response after 3 months of imatinib therapy
2018 Jan
BIOMED RESEARCH INTERNATIONAL 공동저자
Circulating CD3+CD4+CD161+ Cells Are Associated with Early Complications after Autologous Stem Cell Transplantation in Multiple Myeloma
2018 Jan
JOURNAL OF CLINICAL ONCOLOGY 공동저자
Bosutinib Versus Imatinib for Newly Diagnosed Chronic Myeloid Leukemia: Results From the Randomized BFORE Trial
2017 Dec
Clinical Cancer Research 교신저자
Phase III clinical trial (RERISE study) results of Efficacy and safety of radotinib compared with imatinib in newly diagnosed chronic phase chronic myeloid leukemia.
2017 Aug
Cancer 공동저자
Overall survival with ponatinib versus allogeneic stem cell transplantation in Philadelphia chromosome-positive leukemias with the T315I mutation.
2017 Aug
대한면역학회 공동저자
Distinct Clinical Outcomes between Paramedullary and Extramedullary Lesions in Newly Diagnosed Multiple Myeloma
2017 Jul
Leukemia 교신저자
Cobll1 is linked to drug resistance and blastic transformation in chronic myeloid leukemia.
2017 Jun
Oncotarget 공동저자
Long-term clinical outcomes of hematopoietic cell transplantation for intermediate-to-poor-risk acute myeloid leukemia during first remission according to available donor types.
2017 May
Clinica Chimica Acta 공동저자
Practical informativeness of short tandem repeat loci for chimerism analysis in hematopoietic stem cell transplantation.
2017 Apr
Biology of Blood and Marrow Transplantation 공동저자
Clinical Outcome of Autologous Hematopoietic Cell Transplantation in Adult Patients with Acute Myeloid Leukemia: Who May Benefit from Autologous Hematopoietic Cell Transplantation?
2017 Mar
PLoS One 공동저자
The demanding attention of tuberculosis in allogeneic hematopoietic stem cell transplantation recipients: High incidence compared with general population.
2017 Feb
Transplant Infectious Disease 공동저자
Clinical significance of pre-transplant circulating CD3+ CD4+ CD161+ cell frequency on the occurrence of neutropenic infections after allogeneic stem cell transplantation.
2017 Feb
Oncotarget 공동저자
Better transplant outcome with pre-transplant marrow response after hypomethylating treatment in higher-risk MDS with excess blasts
2017 Jan
Journal of Hematology & Oncology 공동저자
High WT1 expression is an early predictor for relapse in patients with acute promyelocytic leukemia in first remission with negative PML-RARa after anthracycline-based chemotherapy: a single-center cohort study.
2017 Jan
Clinical Lymphoma Myeloma and Leukemia 공동저자
Characteristics and Survival Outcome Analysis of Extramedullary Involvement in Adult Patients With t(8;21) Acute Myeloid Leukemia.
2017 Jan
Korean journal of internal medicine 교신저자
BCR-ABL1 transcripts (MR4.5) at post-transplant 3 months as an early predictor for long-term outcomes in chronic myeloid leukemia
2017 Jan
대한내과학회 교신저자
BCR-ABL1 transcripts (MR4.5) at post-transplant 3 months as an early predictor for long-term outcomes in chronic myeloid leukemia
2017 Jan
Acta Derm Venereol 공동저자
Eruptive Melanocytic Naevi Caused by Radotinib Therapy in Patients with Chronic Myeloid Leukaemia: 10 cases and a literature Review.
저서
2012 Apr
책읽는달 공동
굿바이 암 : 암 치료 패러다임을 뒤집은 표적항암제 10년의 기록
2008 Jun
성우 단독
그림으로 이해하는 만성골수성백혈병
2019 Jul
군자출판사 공동
(Current principles and clinical practice of) internal medicine : 임상진료지침
책읽는달 공동
굿바이 암 : 암 치료 패러다임을 뒤집은 표적항암제 10년의 기록
2008 Jun
성우 단독
그림으로 이해하는 만성골수성백혈병
2019 Jul
군자출판사 공동
(Current principles and clinical practice of) internal medicine : 임상진료지침
보도자료
11개국 공동 연구팀, 만성골수성백혈병 4세대 표적항암제 안전성·효능 입증
http://news.khan.co.kr/kh_news/khan_art_view.html?artid=202001072051005&code=900303
만성골수성 백혈병환자 '평생 표적항암제 복용' 불문율 깨지나
https://www.sedaily.com/NewsView/1YXI4BRHPY
4세대 표적항암제 임상 주도한 국내 의료진 "애시미닙 효능 입증…백혈병 완치 시대 연다"
https://www.hankyung.com/it/article/201912264260i
[경기인터뷰] 수원출신, 가톨릭대학교 서울성모병원 김동욱 교수
http://www.kyeonggi.com/news/articleView.html?mod=news&act=articleView&idxno=1327696
병원 옮기자 환자 600명 따라온 ‘백혈병 대부’
http://kormedi.com/1227080/
[김동욱 칼럼] 인간의 고결함과 생명경외에 대하여…
http://www.kyeonggi.com/news/articleView.html?mod=news&act=articleView&idxno=1292866
http://news.khan.co.kr/kh_news/khan_art_view.html?artid=202001072051005&code=900303
만성골수성 백혈병환자 '평생 표적항암제 복용' 불문율 깨지나
https://www.sedaily.com/NewsView/1YXI4BRHPY
4세대 표적항암제 임상 주도한 국내 의료진 "애시미닙 효능 입증…백혈병 완치 시대 연다"
https://www.hankyung.com/it/article/201912264260i
[경기인터뷰] 수원출신, 가톨릭대학교 서울성모병원 김동욱 교수
http://www.kyeonggi.com/news/articleView.html?mod=news&act=articleView&idxno=1327696
병원 옮기자 환자 600명 따라온 ‘백혈병 대부’
http://kormedi.com/1227080/
[김동욱 칼럼] 인간의 고결함과 생명경외에 대하여…
http://www.kyeonggi.com/news/articleView.html?mod=news&act=articleView&idxno=1292866
포스팅
포스팅 내용이 없습니다.
영상자료
[쿠키건강뉴스-체크리포트] 피를 타고 번지는 백혈병, ‘조혈 장애’로 출혈·감염…“혈액검사로 양상 확인, 급성은 주사제 항암요법부터”
http://www.kukinews.com/news/article.html?no=735910
Increase in activity in North Korea's nuclear test site:38 North
http://www.arirang.co.kr/News/News_View.asp?nseq=201717
'만성→급성' 골수성백혈병 악화 비밀 찾았다
https://news.sbs.co.kr/news/endPage.do?news_id=N1004071030&plink=SEARCH&cooper=SBSNEWSSEARCH
[대한암협회] 혈액암에 대한 모든 것 - 대한암협회 김동욱 교수 / 서울성모병원 혈액병원장
https://tv.naver.com/v/15331658
[EBS 명의] 아름다운 날들 - 만성골수성백혈병 전문의 김동욱 교수
https://bestdoctors.ebs.co.kr/bestdoctors/vodReplayView?siteCd=ME&prodId=454&courseId=BP0PAPG0000000014&stepId=01BP0PAPG0000000014&lectId=3053447
[톡투건강 이진한TV] [메디컬현장]조혈모세포이식 세계에서 가장 많이 한 병원, 국내에 있다? 없다?
https://tv.naver.com/v/20390350
http://www.kukinews.com/news/article.html?no=735910
Increase in activity in North Korea's nuclear test site:38 North
http://www.arirang.co.kr/News/News_View.asp?nseq=201717
'만성→급성' 골수성백혈병 악화 비밀 찾았다
https://news.sbs.co.kr/news/endPage.do?news_id=N1004071030&plink=SEARCH&cooper=SBSNEWSSEARCH
[대한암협회] 혈액암에 대한 모든 것 - 대한암협회 김동욱 교수 / 서울성모병원 혈액병원장
https://tv.naver.com/v/15331658
[EBS 명의] 아름다운 날들 - 만성골수성백혈병 전문의 김동욱 교수
https://bestdoctors.ebs.co.kr/bestdoctors/vodReplayView?siteCd=ME&prodId=454&courseId=BP0PAPG0000000014&stepId=01BP0PAPG0000000014&lectId=3053447
[톡투건강 이진한TV] [메디컬현장]조혈모세포이식 세계에서 가장 많이 한 병원, 국내에 있다? 없다?
https://tv.naver.com/v/20390350
발표자료
발표자료 내용이 없습니다.